home / stock / clabf / clabf news

CLABF News and Press, Core One Labs Inc. From 02/09/22

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: CLABF
Market: OTC
Website: lifestyledeliverysystem.com
Menu
CLABF CLABF Quote CLABF Short CLABF News CLABF Articles CLABF Message Board
Get CLABF Alerts

News, Short Squeeze, Breakout and More Instantly...
CLABF - Core One's unit files patent application for biosynthetic production system for psilocybin

Core One Labs (OTCPK:CLABF) said its unit Vocan Biotechnologies filed patent application for protection of its Biosynthetic Production System for Psilocybin. Core One said that with Vocan’s recombinant production system, the subsidiary successfully tested its proof-of-concept for the m...
CLABF - Core One Labs' Successful Patent Application Filing for Protection of its Biosynthetic Production System for Psilocybin Marks a Significant Milestone for the Progression of Psychedelic Health Care

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that following its milestone announcemen...

CLABF - Core One Labs' Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences

VANCOUVER, British Columbia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly owned subsidiary Akome B...

CLABF - Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin

VANCOUVER, British Columbia, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One ” or the “ Company ”) is pleased to announce that its wholly owned subsidiary, Vocan...
CLABF - Core One Labs Special Investor Webcast Rescheduled to Friday, January 21, 2022

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“ Core One ” or the “ Company ”) announces that the special investor webcast (the “ Webcast ”...

CLABF - Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022

VANCOUVER, British Columbia, Jan. 15, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“ Core One ” or the “ Company ”) is pleased to announce, as a follow up to the press release dated January 10, ...

CLABF - Core One Labs Now Also Working to Biosynthesize DMT and Receives License

VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One ” or the “ Company ”) is pleased to announce that it has progressed its work on bios...
CLABF - Core One Labs Applauds Health Canada's Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments

VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) applauds Health Canada for its recent amendment to the Special ...

CLABF - Core One Labs Acquires New Path Laboratories

VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “ Company ” or “ Core One ”) is a research and development company focused on bringing psychedelic medicine...

CLABF - REPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

VANCOUVER, British Columbia, June 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company ”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“ Akome ”) has co...
Previous 10 Next 10